PHARMING GROUP (Netherlands) Today

Equity ratings for PHARMING GROUP are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of August 2019 and ending today, the 28th of July 2021. Click here to learn more.
PHARMING GROUP cannot be verified against its exchange. Apparently, PHARMING GROUP is not available for investing at the moment. Please verify the symbol is currently traded on Amsterdam Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

PHARMING GROUP Stock Profile

Pharming Group N.V., a specialty pharmaceutical company, develops and manufactures biopharmaceutical products in the United States, Europe, and internationally. Pharming Group N.V. is headquartered in Leiden, the Netherlands. PHARMING GROUP operates under Biotechnology classification in Netherlands and is traded on Amsterdam Stock Exchange. It employs 183 people.. The public information regarding PHARMING GROUP's current market price is not available at this time.
PHARMING GROUP is not yet fully synchronised with the market data
PHARMING GROUP has some characteristics of a very speculative penny stock
PHARMING GROUP has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Legal NamePHARMING GROUP
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of PHARMING GROUP's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
PHARMING GROUP (PHARM) is traded on Amsterdam Stock Exchange in Netherlands and employs 183 people. The company currently falls under 'Small-Cap' category with current market capitalization of 623.99 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PHARMING GROUP's market, we take the total number of its shares issued and multiply it by PHARMING GROUP's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. PHARMING GROUP operates under Healthcare sector and is part of Biotechnology industry. The entity has 621.5 M outstanding shares. PHARMING GROUP has accumulated about 63.89 M in cash with 55.83 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1.
Check PHARMING GROUP Probability Of Bankruptcy

PHARMING Stock Against Markets

Picking the right benchmark for PHARMING GROUP stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in PHARMING GROUP stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for PHARMING GROUP is critical whether you are bullish or bearish towards PHARMING GROUP at a given time.
PHARMING GROUP cannot be verified against its exchange. Apparently, PHARMING GROUP is not available for investing at the moment. Please verify the symbol is currently traded on Amsterdam Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PHARMING GROUP stock to make a market-neutral strategy. Peer analysis of PHARMING GROUP could also be used in its relative valuation, which is a method of valuing PHARMING GROUP by comparing valuation metrics with similar companies.
Check out Your Equity Center. Note that the PHARMING GROUP information on this page should be used as a complementary analysis to other PHARMING GROUP's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Tools for PHARMING Stock

When running PHARMING GROUP price analysis, check to measure PHARMING GROUP's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PHARMING GROUP is operating at the current time. Most of PHARMING GROUP's value examination focuses on studying past and present price action to predict the probability of PHARMING GROUP's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move PHARMING GROUP's price. Additionally, you may evaluate how the addition of PHARMING GROUP to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go